Pay-for-Performance Model Being Applied To Drug Makers In Europe, U.S.
Oct 20th 2007Drug InformationPharma Industry
Prescription drug makers are creating pay-for-performance contracts with European state-run health care systems in an effort to “overcome” the systems’ “increasing stinginess about paying for new drugs,” the Wall Street Journal reports. According to the Journal, a rapid increase in drug prices over the past decade has increased the demand on drug companies to be held accountable for the claims they make. [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
